National Brain Tumor Awareness Month

May is National Brain Tumor Awareness Month. Driven by advancement in research, surgical techniques, genetic discoveries and much more, it has never been a better time to take action on brain tumors.

The National Brain Tumor Society (NBTS), an organization committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow, estimates that 700,000 people in the United States are living with a primary brain tumor (80% benign and 20% malignant) and almost 79,000 more will be diagnosed in 2018.

A brain tumor is an abnormal growth of tissue in the brain or central spine that can disrupt proper brain function. Doctors refer to a tumor based on where the tumor cells originated, and whether they are cancerous (malignant) or not (benign). Brain tumors can be deadly, significantly impact quality of life, and change everything for a patient and their loved ones. They do not discriminate, inflicting men, women, and children of all races and ethnicities.

Below are some quick Brain Tumor Facts from the NBTS:

– There are more than 130 different types of brain tumors, many with their own multitude of subtypes.

– The most prevalent brain tumor types in adults are Meningiomas, which make-up 36.6% of all primary brain tumors, and Gliomas (such as glioblastoma, ependymomas, astrocytomas, and oligodendrogliomas), which make-up 74.6% of malignant brain tumors.

– More than any other cancer, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life, meaning malignant brain tumors can often be described as equal parts neurological disease and deadly cancer.

– Even benign brain tumors can be deadly if they interfere with portions of the brain responsible for vital bodily functions.

– The average survival rate for all malignant brain tumor patients is only 34.7% (male is 33.8%, female is 36.4%) and for the most common form of primary malignant brain tumors, glioblastoma multiforme, the five-year relative survival rate is only 5.5%.

– An estimated 16,616 people will die from malignant brain tumors (brain cancer) in 2018.

At our center, we treat brain tumors with the CyberKnife® Robotic Radiosurgery System. CyberKnife painlessly delivers precise beams of high-dose radiation to brain tumors and lesions, without incisions, hospitalization, or long recovery time. CyberKnife is a non-invasive alternative to brain cancer surgery and can be used for brain tumors that are considered inoperable because of their location in the head, for those patients who cannot undergo brain cancer surgery due to their poor medical condition, or who refuse surgery.

For more information about treating brain tumors with CyberKnife technology, please contact us today.

Follow Us